Drug Supply Chain Security Act: DQSA/DSCSA
Prior to January 1, 2015, JAMS was fully compliant with Florida pedigree law which has been incorporated into the DSCSA. In our continuing effort to provide our customers with updated information regarding significant industry developments, we have included a description of the Drug Supply Chain Security Act (DSCSA). The Act took effect January 1, 2015, and provides for a full implementation process over a period of 10 years. The Act imposes requirements on manufacturers, wholesale drug distributors, repackagers and dispensers to verify that all pharmaceutical products are legitimate, utilizing identification and tracing procedures as well as maintaining systems that recognize and report suspicious products. JAMS has always maintained a complete history (at least 6 years as required) of each customer invoice for as long as the customer has been ordering from JAMS.
Please be aware that JAMS places utmost importance on protecting the product supply chain by only purchasing pharmaceuticals from Authorized Distributors of Record (ADRs) or directly from the manufacturer when possible.
In recognition of the pending serialization requirements, we would like to assure you that JAMS Compliance is staying current on what will be required of us as wholesale distributors. Our Compliance team is mindful of what is expected of us and is keeping abreast on all upcoming guidance from regulatory agencies.
- Download - Federal Implementation Timeline